InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Mahal Jeetinder Singh. Insider active across 1 company, notably Jasper Therapeutics, Inc.. In total, 8 reports have been logged. History available since 12 October 2022. The latest transaction was disclosed on 12 December 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Mahal Jeetinder Singh is Chief Operating Officer at Jasper Therapeutics, Inc. There are 8 filings in total. In the 8 most recent filings covered, the modal transaction nature is option exercise, with buy and sell amounts of 0 and 0, over the period from 2022-10-13 to 2024-12-12.